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Purpose of the study
To identify the risk factors for lost to follow-up (LTFU)
among patients accessing antiretroviral therapy in
Uganda.
Methods
A quantitative case control study was done. Records
(cases: 201) of those LTFU were identified and a corre-
sponding number (controls: 202) of records of those still
in the programme were selected. Twenty-three variables
were captured using an excel sheet. The data in the excel
sheet was imported into SAS statistical software for analy-
sis. Odds ratio and p-values were obtained to determine
the strengths of association of various factors. The results
were presented appropriately.
Summary of results
Data on 23 variables were collected from both cases and
controls. The Odds ratio was insignificant in six out of 23
variables, namely: young age (<14 years); male sex; lack of
family support; lack of social support; and few (<2)
household members.
Conclusion
LTFU remains a big problem in Mbale Regional Referral
Hospital infectious disease clinic, the main ART provider
for the government ministry of health system in the east-
ern region. Patient factors, notably gender, age, family
support, social support and number of household mem-
bers, were associated with LTFU at various levels of
strengths of association by Odds ratio.
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